2021 Update of the AGIHO guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy

The worldwide spread of SARS-CoV-2 and the associated infectious disease COVID-19 has posed a unique challenge to medical staff, patients and their families. Cancer patients, particularly those with haematologic malignancies, have been identified to be at high risk to develop severe COVID-19.Since publication of our previous guideline on evidence-based management of COVID-19 in cancer patients, research efforts have continued and new relevant data has come to light, maybe most importantly in the field of vaccination studies.

Lascia un commento